Coronation Fund Managers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,494
Closed -$3.15M 126
2024
Q1
$3.15M Sell
24,494
-90,800
-79% -$10.8M 0.09% 119
2023
Q4
$11.9M Buy
115,294
+19,910
+21% +$1.97M 0.33% 69
2023
Q3
$8.67M Sell
95,384
-21,032
-18% -$1.85M 0.26% 79
2023
Q2
$9.42M Buy
+116,416
New +$9.51M 0.25% 79

Other funds holding NVO

Coronation Fund Managers's NVO Position: Q2 2024 in Review

Coronation Fund Managers sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 24,494 shares — an estimated $3.15M sold.

Coronation Fund Managers first reported a position in NVO in Q2 2023 and held it in 4 quarters. The position peaked at $11.9M in Q4 2023. 1,860 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Coronation Fund Managers reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Coronation Fund Managers sold 24,494 Novo Nordisk shares in Q2 2024, an estimated $3.15M.
  • Coronation Fund Managers first reported a position in Novo Nordisk in Q2 2023 and held it in 4 quarters.
  • Coronation Fund Managers's Novo Nordisk position peaked at $11.9M in Q4 2023.
  • 1,860 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Coronation Fund Managers's 13F filing for Q2 2024, filed 18 Jul 2024.